approval
saveTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
community read0 votes
Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalDec 22, 2025 · 283d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalDec 15, 2023 · 1021d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalJun 28, 2018 · 3017d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalAug 29, 2017 · 3320d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalFeb 17, 2017 · 3513d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalFeb 19, 2016 · 3877d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalDec 4, 2015 · 3954d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalApr 30, 2015 · 4172d ago
same company · ±60 days · 6
- approvalADZENYS XR-ODT (AMPHETAMINE) — FDA approvalJan 4, 2017
- approvalamfetamine ER: DYANAVEL XR (AMPHETAMINE) — FDA approvalJan 4, 2017
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 16, 2016
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 16, 2016
- approvalTUZISTRA XR: TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalFeb 17, 2017
- approvalADZENYS XR-ODT (AMPHETAMINE) — FDA approvalNov 18, 2016
comments(0)
5-min edit window · permanent after that